RNAimmune competitorsClear all

RNAimmune's top competitors include CureVac, RNACure, Stemirna and Ufovax.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
RNAimmune
RNAimmune
RNAimmune is a company specializing in the field of messenger RNA (mRNA) technology.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
RNACure
RNACure
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
Stemirna
Stemirna
Stemirna is an RNA technology-based drug development company.
Ufovax
Ufovax
Ufovax is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.
Founding Date
Founding Date
N/A
Founding Date
2000
Founding Date
2019
Founding Date
2016
Founding Date
2018
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Gaithersburg, US HQ
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
Shanghai, CN HQ
Locations
Shanghai, CN HQ
Locations
Wilmington, US HQ
Employees
Employees
N/A
Employees
4004% increase
Employees
5
Employees
N/A
Employees
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
210991
Alexa Website Rank
N/A
Alexa Website Rank
189452
Alexa Website Rank
N/A

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
2 (May, 2020)
Patent Applications
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
233 (May, 2020)
Patents Issued
N/A
Patents Issued
2 (May, 2020)
Patents Issued
1 (May, 2020)
Platforms
Platforms
N/A
Platforms
N/A
Platforms
2 (May, 2020)
Platforms
3 (May, 2020)
Platforms
N/A

Funding

Latest funding round
Latest funding round
$ 10m (7 months ago)
Latest funding round
$ 640m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 188m (6 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 12.4m
Total funding raised
$ 1.1b
Total funding raised
N/A
Total funding raised
$ 206.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

CureVac
HQ
Tübingen, DE
Employees
400↑ 4% increase

CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.

View company
RNACure
HQ
Shanghai, CN
Employees
5

RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.

View company
Stemirna
HQ
Shanghai, CN

Stemirna is an RNA technology-based drug development company.

View company
Ufovax
HQ
Wilmington, US

Ufovax is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.

View company